ArticleBone2016

Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease.

Jeffry S Nyman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.